AK

Anil Kumar Singh

Active Director Director DIN 10713548
DIN 10713548 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Anil Kumar Singh

Data last updated:

Anil Kumar Singh is a Director at Solvent Drugs Private Limited (since 2024). The company operates in Paper. Solvent Drugs Private Limited reported revenue of ₹5,600 (FY 2025).

DIN 10713548
Primary Designation Director
Industry Paper
First Appointment 21 Jul 2024
Oldest Company Age 2 yrs
Largest company Solvent Drugs Private Limited · ₹5,600 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Solvent Drugs Private Limited U21001CT2024PTC016617
Director21 Jul 20242024₹5,600 (FY 2025)Active

Board colleagues of Anil Kumar Singh

NameDINCompanyDesignation
Saroj Singh10859324Solvent Drugs Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Solvent Drugs Private Limited
Premium access

Shareholding and investment profile for Anil Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar Singh

Anil Kumar Singh currently holds 1 directorship: Solvent Drugs Private Limited (Director, since 21 Jul 2024, revenue ₹5,600 (FY 2025)).

Anil Kumar Singh was first appointed on 21 Jul 2024 as Director at Solvent Drugs Private Limited.

The current boards of Anil Kumar Singh's companies include Saroj Singh (Solvent Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available